TCR2 Therapeutics Inc logo

TCRR - TCR2 Therapeutics Inc News Story

$16.92 0.1  0.4%

Last Trade - 07/08/20

Sector
Healthcare
Size
Mid Cap
Market Cap £411.1m
Enterprise Value £315.2m
Revenue £n/a
Position in Universe 2877th / 6362

BRIEF-TCR² Therapeutics Reports Q3 Loss Per Share Of $0.58

Tue 12th November, 2019 12:25pm
Nov 12 (Reuters) - TCR2 Therapeutics Inc  TCRR.O :
    * TCR² THERAPEUTICS REPORTS THIRD QUARTER 2019 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * TCR2 THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.58

Source text for Eikon:  ID:nGNX2X9k5H 
Further company coverage:  TCRR.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.